Ethics
CP Activities
Daewoong Pharmaceutical is actively engaged in the CP activities.
- 2023
- 1st ex-post audit on ISO 27001 (information security)/ISO 27701 (personal information protection) international standard certifications
- 1st ex-post audit on ISO 37001 (anti-bribery management system) international standard certification (after certification renewal)
- 2022
- Officers and employees company-wide sign the anti-corruption and fair competition pledge (1,907 officers and employees)
- General and intensive fair-competition training for new transferees of the sales and marketing department for the first half of the year (26 employees)
- CP/anti-competition training for interns (16 interns)
- Became the first company to simultaneously obtain ISO27001(information security) and ISO27701(personal information protection) certifications
- Signed the 2022 Korean Association for Industrial Technology Security Project for Enhancement of Security at Mid-Size Enterprises and received government subsidies
- Conducted due diligence on product information sessions and symposia where lodging is provided
- 5th advanced development phase for the economic benefit and expenditures reporting system (process automation and improved monitoring efficiency)
- General and intensive fair-competition training for new transferees of the sales and marketing department for the second half of the year
- Received a regular CP audit for LG Life Sciences partners
- Received a regular CP audit for AstraZeneca Korea partners
- Regular update of the 2022 company-wide corruption risk assessment report
- Conducted 2022 internal audit on anti-corruption management (random selection of 36 teams from headquarters, research center, and factories)
- 2022 Anti-corruption CEO management review report
- Anti-corruption training for all employees (1,847 persons)
- 2022
- Officers and employees company-wide sign the anti-corruption and fair competition pledge (1,907 officers and employees)
- General and intensive fair-competition training for new transferees of the sales and marketing department for the first half of the year (26 employees)
- CP/anti-competition training for interns (16 interns)
- Became the first company to simultaneously obtain ISO27001(information security) and ISO27701(personal information protection) certifications
- Signed the 2022 Korean Association for Industrial Technology Security Project for Enhancement of Security at Mid-Size Enterprises and received government subsidies
- Conducted due diligence on product information sessions and symposia where lodging is provided
- 5th advanced development phase for the economic benefit and expenditures reporting system (process automation and improved monitoring efficiency)
- General and intensive fair-competition training for new transferees of the sales and marketing department for the second half of the year
- Received a regular CP audit for LG Life Sciences partners
- Received a regular CP audit for AstraZeneca Korea partners
- Regular update of the 2022 company-wide corruption risk assessment report
- Conducted 2022 internal audit on anti-corruption management (random selection of 36 teams from headquarters, research center, and factories)
- 2022 Anti-corruption CEO management review report
- Anti-corruption training for all employees (1,847 persons)
- 2021
- 24th amendment to CP SOP
- Conducted anti-corruption and CP training for all employees for 2021
- Conducted training and instruction of marketing department personnel on rebate prevention and fair competition (completed by 413 employees)
- Provided general and intensive instructions on fair competition for newly transferred members of the sales and marketing department (completed by 20 employees)
- ISO37001 certification renewed
- Continuing education and renewal of certification for certified compliance professionals (CCPs) (current number of certified professionals: 7 Class I professionals, 1 Class II professional)
- ISO37001 examiner certification acquired (2 employees)
- Expanded communication channels on compliance regulations and laws (FAQ notice and internal inquiry boards)
- 11th CP committee (a total of 62 new sales and marketing plans reviewed, 9 sent back)
- Exhaustive review of sales and marketing budget expenditures
- Three instances of on-site due diligence on product information sessions where invitees were provided lodging
- 2020
- Made the 23rd revision for CP SOP
- Strengthened CP monitoring for co-promotion product marketing activities
- Advanced the economic interest expense report system (3rd time)
- Tightened standards for product presentations targeting health professionals
- Created online CP Q&A/FAQ bulletin boards
- 2020: Attended KPBMA ethical management academy/workshop
- 2020: Company-wide anti-corruption training
- 2020: Sales/marketing CP training
- ISO 37001 ex-post audit (3rd year)
- Added 1 CCP-certified person
- 2019
- Conducted follow-up review for ISO 37001 (2nd year)
- Advanced the economic interest expense report system (2nd time)
- Invited an outside expert to provide compliance training to employees
- Published CP Handbook 5th Edition (Supplementary)
- Ensured that all CP staff had CCP Level 1 qualification
- Reinforced the CP operating process
- 2018
- Obtained ISO 37001 certification of anti-bribery management
※ International anti-bribery management system
- Developed an economic interest expense report system
- Published CP Handbook 5th Edition
- Ensured that 3 employees newly acquired Certified Compliance Professional (CCP) Level 1
- 2017
- Received AA rating in CP rating 2 consecutive times
(first in the pharmaceutical industry)
- Send CP letters to all management and employees twice a month
(send relevant laws/regulations and issues)
- Constructed ‘economic profit expenditure report’ system
- 2016
- Pre-post inspection for constructing a CP monitoring CES system
- Publish CP FAQ guidebook
- Newly establish the Daewoong Pharmaceutical ‘webzine’ compliance board
- CP work organization → Legal team/CP team operated separately
- 2015
- Received AA rating in CP ratings
(first in the pharmaceutical industry, highest rating)
- Awarded ‘Presidential Medal’ on Fair Trade Day for autonomous compliance manager
- Published 4th CP handbook
- Foster holders of grade 1 compliance management experts
- Operate legal CP team (appointed legal advisor attorney)
- 2014
- Published third CP handbook
- Newly organized CP team directly under the CEO
- In-company cyber classroom
- Newly established fair trade training course
(8 classes, supported by the company)
- Published ethical management handbook
- 2011
- Published second CP handbook
- Enacted integrated CP regulations for Daewoong Group
- 2008
- Published the first CP handbook in the pharmaceutical industry
- 2007
- Introduced fair trade autonomous compliance program
- Established compliance organization